RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 

Under RAPS

Posted 01 September 2010

RAPS has just published the highly anticipated English language edition of its comprehensive guide to regulatory requirements for pharmaceuticals, biologics, in vitro diagnostics and medical devices marketed in Japan.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe